The Global Governance of HIV/AIDS

The Global Governance of HIV/AIDS

Intellectual Property and Access to Essential Medicines

Elgar Intellectual Property and Global Development series

Edited by Obijiofor Aginam, John Harrington and Peter K. Yu

The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.

Chapter 11: The global governance of HIV/AIDS and the rugged road ahead: An epilogue

Peter K. Yu

Subjects: development studies, law and development, law - academic, health law, intellectual property law, international economic law, trade law, law and development, politics and public policy, international relations, public policy


Since its discovery more than three decades ago, AIDS has grown from a disease afflicting only a small portion of the world’s population to one having major deleterious effects on an ever-growing number of people. To date, over 30 million adults and about 2.5 million children have been infected with the disease (UNAIDS, 2010, p. 180). Another 25 million have died owing to the infection (The Economist, 2011). If we count family members, loved ones and the numerous professionals and volunteers who cared for the infected, HIV/AIDS has disturbed the lives of an incalculable number of individuals and communities from around the world. Yet, despite the gravity of this public health crisis and the many dedicated responses, we are still nowhere close to finding a solution to containing, if not curing, the disease. As the Joint United Nations Programme on HIV/AIDS (UNAIDS) lamented in its latest report, about two-thirds of the estimated 15 million people living with HIV in less developed countries have no access to affordable life-saving medications (UNAIDS, 2010, p. 7). Such limited access has renewed fears that the disease will continue to plague the globe for decades to come. In the past two decades, a global governance structure has slowly emerged to address the HIV/AIDS crisis. From programs developed by the World Health Organization (WHO) to the ongoing negotiations in the Doha Development Round of Trade Negotiations (Doha Round) at the World Trade Organization (WTO), governments have worked closely to confront the crisis head-on.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information